Traditional cancer therapies are often accompanied by high toxicity and side effects. We are able to apply our proprietary methods to help design targeted immune therapies with superior response rates and safety profiles  through harnessing the bodies own immune system. This approach holds a promise for developing truly safe cures for solid tumors.  We develop our hypotheses and targets via data, but  test these approach through our own lab work and experience in drug discovery to continuosly build, refine and hone our data and algorithms.